Fluent Elara THC-CBD Blend Vape Cartridge – 600mg

(1 customer review)


Balanced THC+CBD BlendElara is a blend of Cannabis sativa and Cannabis indica hybrid strains with an approximate 1:1 ratio of THC:CBD with only mild euphoria. Elara harmoniously blends the top characteristics of each strain into one product. Patients can benefit tremendously from the synergistic effects of THC + CBD in treating various types of medical conditions. Elara also contains a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.

Current medical literature supports the use of CBD+THC rich products for the treatment of all conditions approved for medical cannabis.

CBD Content: Approximately 50%

THC Content: Approximately 50%

THC to CBD Ratio: 1:1

Dosing Units: Each vaporizer 600 mg cartridge contains 2 mg CBD/THC inhalation

Total Doses: Approximately 300 inhalations per cartridge (1ml)

Sold By: Fluent

Categories: Vape Cartridges, CBD THC Balanced 1:1

Leave Your Review: Write A Review

Out of stock

1 review for Fluent Elara THC-CBD Blend Vape Cartridge – 600mg

  1. Armando R.

    Fluent’s Elara 1:1 vape cart is a lovely choice for anyone who is prone to high THC anxiety. I suffer from anxiety and panic attacks. It should be noted that it does have some MCT oil (~300mg) in it, but that’s acceptable since the main oils are flavorful full spectrum extracts. The taste upon inhalation is slightly peppery and earthy with an exhalation after taste almost like chocolate. It’s effects are very Indica-like and come on smoothly as opposed to a sharp punch in the face. Great body high with a mind numbing effect to calm a loud mind. I’ve been using since the dark ages and consider this 1:1 blend one of the best available in south florida.

Add a review

Your email address will not be published. Required fields are marked *

Product Description

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms. If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2.

Cash & CanPay Accepted

Elara® is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.